pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics Europe clinical programs — 199 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 1032
- Drugs
- 612
- Patents
- 3720
United Therapeutics Europe projects
199 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.
United Therapeutics Europe has 199 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
probiotic strain Bb-12
United Therapeutics Europe Ltd
Infections, Respiratory
1 trial -
radiation therapy
United Therapeutics Europe Ltd
Bladder Cancer
1 trial -
recombinant interferon alfa
United Therapeutics Europe Ltd
Melanoma (Skin)
1 trial -
selenase (selenium)
United Therapeutics Europe Ltd
Osteoporosis
1 trial -
trastuzumab
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
treprostinil sodium
United Therapeutics Europe Ltd
Liver Transplant
1 trial -
zinc sulphate dietary supplement
United Therapeutics Europe Ltd
Nutrition
1 trial
Frequently asked questions
How many clinical projects does United Therapeutics Europe have?
199 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.